✦ LIBER ✦
Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis
✍ Scribed by Kai, A. C.; Flohr, C.; Grattan, C. E.
- Book ID
- 121792052
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 89 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0307-6938
No coin nor oath required. For personal study only.